Back to search

Belgium· BE-AMP-SAM230404-00

Diclofenac IBSA Farmaceutici 140 mg

A diclofenac product containing diclofenac epolamine, registered in Belgium by IBSA Farmaceutici Italia. The same ATC class is registered in 14 of our 19 countries.

ATC M02AA15

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDiclofenac IBSA Farmaceutici 140 mgATCM02AA15REGISTER NO.BE-AMP-SAM230404-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Diclofenac is registered in 14 of 19 countries.

Countries holding a registration under ATC M02AA15 (diclofenac), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Diclofenac · ATC M02AA15

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of diclofenac costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Diclofenac · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.43
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Diclofenac Epolamine
Manufacturer
IBSA Farmaceutici Italia
Country
Belgium (BE)
ATC code
M02AA15
ATC class
Diclofenac
Defined daily dose
0.1 g, T
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    1707553
  • be_apb
    1707561

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

131 interactions on record for diclofenac.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Diclofenac · interactions on record

131 records

  • 9 severe
  • 122 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Diclofenac in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diclofenac products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Flector Ep
  • Cyprus · Flector Tissugel
  • Czechia · Flalgo, Flector
  • Germany · Flector
  • Denmark · Flector
  • Spain · Flectormed
  • France · Diclofenac Urgo, Flector
  • United Kingdom (Northern Ireland) · Dicloalgan, Flector Tissugel
  • Greece · Dicloplast, Miniflampatch
  • Hungary · Diclofenac Epolamine Cooper, Flector
  • Ireland · Diclofenac, Diclofenac Ibsa Farmaceutici Italia
  • Italy · Calminemed, Dicloreum
  • Luxembourg · Flector Tissugel
  • Poland · Diklofenak Viatris, Dolofest
  • Portugal · Diclofenac Farmoz, Flector Tissugel
  • Sweden · Flector
  • Slovakia · Flectopar, Flector

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fcea885c-08f9-4417-8717-7aeb05efca99
GET /v1/drugs/fcea885c-08f9-4417-8717-7aeb05efca99?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Impregnated dressing",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Diclofenac IBSA Farmaceutici 140 mg",
  "name_fr": "Diclofenac IBSA Farmaceutici 140 mg",
  "name_nl": "Diclofenac IBSA Farmaceutici 140 mg",
  "amp_code": "SAM230404-00",
  "strengths": [
    "180.0000",
    "139.0000",
    "16.8000",
    "14.0000",
    "7.0000",
    "420.0000",
    "560.0000",
    "5600.0000",
    "28.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Diclofenac Epolamine",
    "Diclofenac Sodium",
    "Disodium Edetate",
    "Methyl Parahydroxybenzoate",
    "Propyl Parahydroxybenzoate",
    "Propylene Glycol",
    "Sodium Polyacrylate",
    "Sorbitol",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Diclofenac",
  "authorisation_numbers": [
    "BE230404"
  ]
}

See everything about diclofenac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.